Detection of drug–drug interactions through data mining studies using clinical sources, scientific literature and social media
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Drug-drug interactions (DDIs) constitute an important concern in drug development and postmarketing pharmacovigilance. They are considered the cause of many adverse drug effects exposing patients to higher risks and increasing public health system costs. Methods to follow-up and discover possible DDIs causing harm to the population are a primary aim of drug safety researchers. Here, we review different methodologies and recent advances using data mining to detect DDIs with impact on patients. We focus on data mining of different pharmacovigilance sources, such as the US Food and Drug Administration Adverse Event Reporting System and electronic health records from medical institutions, as well as on the diverse data mining studies that use narrative text available in the scientific biomedical literature and social media. We pay attention to the strengths but also further explain challenges related to these methods. Data mining has important applications in the analysis of DDIs showing the impact of the interactions as a cause of adverse effects, extracting interactions to create knowledge data sets and gold standards and in the discovery of novel and dangerous DDIs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Benefits and drawbacks of electronic health record systems
Menachemi, N., & Collum (2011) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s12985 · Cited by 909
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
Ejim, L., Farha, M. A., Falconer, S. B., Wildenhain, J., Coombes, B. K., Tyers, M., Brown, E. D., & Wright, G. D. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.559 · Cited by 525
Hohl, C. M., Dankoff, J., Colacone, A., & Afilalo, M. (2001) · Annals of Emergency Medicine · doi:10.1067/mem.2001.119456 · Cited by 477
Withdrawal of Cerivastatin from the World Market
Furberg, C. D., & Pitt, B. (2001) · Trials · doi:10.1186/cvm-2-5-205 · Cited by 400
Uses of Electronic Health Records for Public Health Surveillance to Advance Public Health
Birkhead, G. S., Klompas, M., & Shah, N. R. (2015) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031914-122747 · Cited by 345 · cited 1×
“EHRs are useful to evaluate and improve many processes important for the hospital functionality, to make better decisions and provide more coordinated health care [145].”
Tatonetti, N. P., Fernald, G. H., & Altman, R. B. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000214 · Cited by 203 · cited 20×
“A similar method was applied to identify DDI signals for the prolongation of the QT interval in FAERS and validate the predictions using electrocardiogram laboratory data in EHRs at Columbia University Medical Center [66].”
InfluentialAnalysis of overridden alerts in a drug-drug interaction detection system
Mille, F., Schwartz, C., Brion, F., Fontan, J.-E., Bourdon, O., Degoulet, P., & Jaulent, M.-C. (2008) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzn038 · Cited by 47
Data mining for potential adverse drug–drug interactions
Hammann, F., & Drewe, J. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.894507 · Cited by 19
Cited by
Modeling polypharmacy side effects with graph convolutional networks
Zitnik, M., Agrawal, M., & Leskovec, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty294 · Cited by 1,501
Noguchi, Y., Tachi, T., & Teramachi, H. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab347 · Cited by 285
Toxicity prediction based on artificial intelligence: A multidisciplinary overview
Pérez Santín, E., Rodríguez Solana, R., González García, M., García Suárez, M. D. M., Blanco Díaz, G. D., Cima Cabal, M. D., Moreno Rojas, J. M., & López Sánchez, J. I. (2021) · WIREs Computational Molecular Science · doi:10.1002/wcms.1516 · Cited by 153
Recent advances in biomedical literature mining
Zhao, S., Su, C., Lu, Z., & Wang, F. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa057 · Cited by 134
“Existing methods for DDI extraction include co-occurrencebased, rule-based and machine learning approaches [121].”
MethodXiong, G., Yang, Z., Yi, J., Wang, N., Wang, L., Zhu, H., Wu, C., Lu, A., Chen, X., Liu, S., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab880 · Cited by 133
Machine Learning in Pharmacometrics: Opportunities and Challenges
McComb, M., Bies, R., & Ramanathan, M. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14801 · Cited by 128
“DDIs are a serious concern in drug development that lead to approximately 30% of clinical ADE.(127) ML approaches are well suited for identifying complex associations from large databases and have been used for predicting DDIs.”
BackgroundEnsemble method–based extraction of medication and related information from clinical texts
Kim, Y., & Meystre, S. M. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocz100 · Cited by 56
Metadata
- Authors
- Vilar, S., Friedman, C., & Hripcsak, G.
- Venue
- Briefings in Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-02-17
- Volume
- 19
- Issue
- 5
- Pages
- 863-877
- ISSN
- 1467-5463 (ISSN-L)
- 1477-4054
- OpenAlex
- W2589489260
- Cited by
- 153
- References
- 9
- FWCI
- 20.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.